Arjun Balar is a Senior Vice President of Global Clinical Development at Eli Lilly and Company and an Associate Professor of Medicine at NYU Grossman School of Medicine. They currently serve as a Board Member at Volastra Therapeutics. Previously, Arjun held various roles, including Medical Oncology Fellow at Memorial Sloan-Kettering Cancer Center and Vice President of Global Clinical Development at Loxo Oncology at Lilly. Arjun earned a BS in Finance from the University of Florida and an MD from the University of South Florida College of Medicine.
This person is not in any teams
This person is not in any offices